Bipolar disorder is a common psychiatric illness with devastating consequences for affected individuals, their families, and society. The exact causes of this illness are presently not known, despite considerable research effort dedicated to this objective, in part due to the complexity of the illness, both in its phenotypes and its etiology. Due to this complexity, and although twin and adoption studies clearly demonstrate that bipolar disorder is highly heritable, risk-gene- identification efforts for this illness have been hampered by low power. Research into the biological basis of bipolar disorder is currently advancing in humans and--to a lesser extent--in animals, more or less independently. Each independent line of investigation (i.e., animal and human studies) is contributing to the incremental gains in knowledge of bipolar disorder etiology witnessed in the last decade. Yet, it is now clear that the lack of integration between these two lines of investigation is hindering the pace of risk-gene identification or, perhaps more accurately, constitutes a missed opportunity for optimizing the approach to gene discovery. Our group has laid the foundation for overcoming this barrier to resolving the genetic etiology of bipolar disorder by implementing a convergent functional genomics approach that capitalizes on multiple sources of information from various disciplines to narrow the search for bipolar disorder susceptibility loci and genes, and increase the stringency and accuracy of designating a candidate gene as a causal factor in the illness. In the present application, we propose to apply this methodology to the study of distinct features of the bipolar disorder phenotype (e.g., cycling and switching), and extend it by testing novel candidate genes for association with the illness in a phenotypically enriched and presumably more homogeneous--sample of patients with pediatric onset of bipolar disorder. The goal of this work is to identify the genes that contribute to the emergence of bipolar disorder and regulate its most prominent features: mood cyclicity and switching. The identification of these genes may have numerous consequences for the future of bipolar disorder, including the improvement of diagnostic approaches to the illness, the construction of individually tailored pharmacological and psychosocial treatments for and interventions in the progression of the illness, and, ultimately, the prevention of its occurrence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH071912-01
Application #
6830999
Study Section
Special Emphasis Panel (ZMH1-NRB-Q (05))
Program Officer
James, Regina Smith
Project Start
2004-09-02
Project End
2008-08-31
Budget Start
2004-09-02
Budget End
2005-08-31
Support Year
1
Fiscal Year
2004
Total Cost
$411,769
Indirect Cost
Name
University of California San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Kurian, S M; Le-Niculescu, H; Patel, S D et al. (2011) Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 16:37-58
Patel, S D; Le-Niculescu, H; Koller, D L et al. (2010) Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet 153B:850-77
Bousman, Chad A; Chana, Gursharan; Glatt, Stephen J et al. (2010) Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. Am J Med Genet B Neuropsychiatr Genet 153B:1336-41
Bousman, Chad A; Chana, Gursharan; Glatt, Stephen J et al. (2010) Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet 153B:494-502
Le-Niculescu, H; Kurian, S M; Yehyawi, N et al. (2009) Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14:156-74
McGrath, Casey L; Glatt, Stephen J; Sklar, Pamela et al. (2009) Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 9:70
Le-Niculescu, H; Patel, S D; Bhat, M et al. (2009) Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet 150B:155-81
Glatt, S J; Chandler, S D; Bousman, C A et al. (2009) Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study. Curr Pharmacogenomics Person Med 7:164-188
Chen, Christine; Glatt, Stephen J; Tsuang, Ming T (2008) The tryptophan hydroxylase gene influences risk for bipolar disorder but not major depressive disorder: results of meta-analyses. Bipolar Disord 10:816-21
Le-Niculescu, H; McFarland, M J; Ogden, C A et al. (2008) Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet 147B:134-66

Showing the most recent 10 out of 13 publications